Logo Image
News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtablesShorts
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Elias K. Manavathu, PhD

Advertisement

Articles by Elias K. Manavathu, PhD

Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

ByJose A. Vazquez, MD,Elias K. Manavathu, PhD
February 25th 2020

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.

Advertisement

Latest Updated Articles

  • Medical Importance of Microbial Biofilms in the Management of Infectious Diseases
    Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

    February 25th 2020



Advertisement
Advertisement

Trending on Contagion Live

1

Once-Weekly Islatravir/Lenacapavir Meets Phase 3 Primary End Point

2

FDA Authorizes First Multiplex PCR Assay for HSV, VZV, and Mpox Skin Lesions

3

The Latest on the Cyclosporiasis Outbreak: An FDA False Positive Test, and What Treatment Looks Like

4

Cyclosporiasis Case Count Tops 7000 as Lettuce Probe Continues

5

The Potential for Antivirals in Dengue Prophylaxis and Treatment

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us